- $89.39bn
- $93.28bn
- $403.43bn
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson beats Q4 profit estimates, maintains long-term profit growth forecast
Brief: McKesson Q4 Adjusted EPS USD 11.69 Vs. IBES Estimate USD 11.6
Brief: Mckesson Corp Enters New Revolving Credit Facility On April 24, 2026
Deals of the day-Mergers and acquisitions
McKesson sells minority stake in surgical supplies unit to Apollo Funds for $1.25 billion (updated)
McKesson signs $1.25 billion agreement with Apollo Funds for minority interest
Brief: Mckesson Signs Agreement With Apollo Funds For Strategic Minority Interest In Medical-Surgical Solutions
Led By Spark Capital And Transformation Capital
Brief: Mckesson Corp - Subsidiaries Enter Credit Agreement On April 1, 2026 - SEC Filing
U.S. RESEARCH ROUNDUP- Carnival, Five Below, McKesson
McKesson picks Sysco's Cheung to succeed retiring CFO Vitalone (updated)
McKesson CFO Vitalone to retire
Brief: Mckesson Announces Planned CFO Transition
U.S. RESEARCH ROUNDUP-KKR, Sirius XM, Workday
U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems
McKesson boosts 2026 profit forecast amid specialty drug growth
McKesson rises after raising annual profit forecast